027 Will Refractory Patients Respond to Erenumab in the Real World?

Journal of Neurology, Neurosurgery and Psychiatry - United Kingdom
doi 10.1136/jnnp-2019-anzan.26
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Can We Predict Whether Our Patients Will Respond to the Antipsychotic Drug Prescribed?

BJPsych. International
2016English

Real‐world Treatment Patterns and Outcomes in Refractory Metastatic Colorectal Cancer

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2019English

Correction To: Developing Real-World Comparators for Clinical Trials in Chemotherapy-Refractory Patients With Gastric Cancer or Gastroesophageal Junction Cancer

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2019English

Will Higher Tc Superconductors Be Useful? Fundamental Issues From the Real World

MRS Bulletin
Materials ScienceTheoretical ChemistryCondensed Matter PhysicsPhysical
2011English

Editorial: Accumulating Data About Ustekinumab in Refractory Crohn's Disease in Real World Experience

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Clinicopathological Features Predict Outcomes in Patients With Radioiodine‐Refractory Differentiated Thyroid Cancer Treated With Sorafenib: A Real‐World Study

Oncologist
Cancer ResearchMedicineOncology
2020English

Real-World Results of Ibrutinib in Relapsed/Refractory CLL in France: Early Results on a Large Series of 428 Patients

American Journal of Hematology
Hematology
2017English

The Real Challenge to Free Will and Responsibility

Trends in Cognitive Sciences
Cognitive PsychologyPhysiological PsychologyNeuropsychologyExperimentalCognitive Neuroscience
2008English

I Live in the Real World. My Patients Do, Too

Clinical Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy